DayTwo, Microbiome Startup for Diabetes, Raises $31MM for U.S. Growth
Jun 26, 2019
The San Francisco Business Times’ Hannah Norman covered DayTwo’s recent fundraising event. Below is a short excerpt from the article as well as a link read the entire story.
“DayTwo has snagged $31 million as it looks to provide nutritional support to the 30 million people living with type 2 diabetes across the United States.”
“It’s a huge market that’s very underserved with regard to food and nutrition that’s effective in helping them,” said DayTwo president Josh Stevens. “That’s why we’re really spending our effort there.”
The San Francisco and Tel Aviv, Israel-based microbiome testing company offers glycemic control support for people with type 2 diabetes by tailoring their nutritional recommendations on an individual basis.”